This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics, Inc., Pfizer Corporation. Active years: 2018-2026.
Company Filing History:
4 out of 4 
3 out of 5 
1 out of 4,486 
Years Active: 2018-2026
Title: The Innovative Contributions of David Christopher Limburg
Introduction
David Christopher Limburg is a notable inventor based in Salem, Connecticut, who has made significant contributions to the field of pharmaceutical sciences. With a total of seven patents to his name, Limburg's work focuses on developing compounds that address critical health issues.
Latest Patents
One of Limburg's latest patents is titled "Substituted 1,2-oxaborolan-2-ols as PDE4 inhibitors." This invention relates to boron-containing compounds that inhibit phosphodiesterase 4 (PDE4). The patent also encompasses pharmaceutical compositions containing these compounds and methods for treating diseases, conditions, or disorders that can be ameliorated by the inhibition of PDE4. Another significant patent is "Bicyclic heteroaryl derivatives as CFTR potentiators." This invention involves 5,7-disubstituted-imidazo[5,1-f][1,2,4]triazine-4-amine derivatives, which are potentiators of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR). The patent details pharmaceutical compositions comprising these compounds, which are useful for treating cystic fibrosis, asthma, chronic obstructive pulmonary disease, and other CFTR-associated disorders.
Career Highlights
Throughout his career, Limburg has worked with prominent organizations such as Cystic Fibrosis Foundation Therapeutics, Inc. and the Cystic Fibrosis Foundation. His innovative work has contributed to advancements in treatments for various respiratory and metabolic conditions.
Collaborations
Limburg has collaborated with notable professionals in his field, including Joseph Walter Strohbach and John Paul Mathias. These collaborations have further enhanced the impact of his inventions.
Conclusion
David Christopher Limburg's contributions to pharmaceutical innovation demonstrate his commitment to improving health outcomes through scientific research and development. His patents reflect a dedication to addressing complex medical challenges, making him a significant figure in the field of invention.